Panic prescribing has become omnipresent during the COVID-19 pandemic.
作者信息
Caplan Arthur L, Upshur Ross
机构信息
Division of Medical Ethics, New York University Grossman School of Medicine, New York, New York, USA.
Department of Family and Community Medicine and.
出版信息
J Clin Invest. 2020 Jun 1;130(6):2752-2753. doi: 10.1172/JCI139562.
Abstract
摘要
相似文献
1
Panic prescribing has become omnipresent during the COVID-19 pandemic.在新冠疫情期间，恐慌性开药现象已无处不在。
J Clin Invest. 2020 Jun 1;130(6):2752-2753. doi: 10.1172/JCI139562.
2
Ebola Response Priorities in the Time of Covid-19.新冠疫情期间的埃博拉应对重点
N Engl J Med. 2020 Sep 24;383(13):1202-1204. doi: 10.1056/NEJMp2025512.
3
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.在大流行期间治疗新冠病毒病——超说明书用药、同情用药及随机临床试验
JAMA. 2020 May 19;323(19):1897-1898. doi: 10.1001/jama.2020.4742.
4
Missed Opportunities on Emergency Remdesivir Use.瑞德西韦紧急使用中的错失机会
JAMA. 2020 Jul 28;324(4):331-332. doi: 10.1001/jama.2020.11932.
5
COVID-19 pandemic: what can pharmaceutical formulation and drug delivery experts offer?新冠疫情：药物制剂与药物递送专家能提供什么？
Pharm Dev Technol. 2020 Jul;25(6):649. doi: 10.1080/10837450.2020.1764670.
6
COVID-19: Small-Molecule Clinical Trials Landscape.新冠病毒病（COVID-19）：小分子药物临床试验全景
Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334.
7
COVID-19 amidst Ebola's retreat.在埃博拉疫情消退之际的新冠疫情。
Science. 2020 May 1;368(6490):445. doi: 10.1126/science.abc4859.
8
Cationic drugs and COVID-19.阳离子药物与 COVID-19。
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420966078. doi: 10.1177/2058738420966078.
9
COVID-19: A Defining Moment for Clinical Pharmacology?新型冠状病毒肺炎：临床药理学的决定性时刻？
Clin Pharmacol Ther. 2020 Jul;108(1):11-15. doi: 10.1002/cpt.1876.
10
Adapting Ebola training to educate healthcare workers during the SARS-2-CoV pandemic.调整埃博拉培训以在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行期间对医护人员进行教育。
Am J Disaster Med. 2020;15(2):137-140. doi: 10.5055/ajdm.2020.0363.
引用本文的文献
1
Ethical challenges of clinical trials with a repurposed drug in outbreaks.突发传染病中重新定位药物的临床试验的伦理挑战。
Med Health Care Philos. 2023 Jun;26(2):233-241. doi: 10.1007/s11019-023-10140-4. Epub 2023 Mar 7.
2
Top five ethical lessons of COVID-19 that the world must learn.新冠疫情的五大全球必须汲取的伦理教训。
Wellcome Open Res. 2021 Jan 29;6:17. doi: 10.12688/wellcomeopenres.16568.1. eCollection 2021.
3
COVID-19 and the generation of novel scientific knowledge: Research questions and study designs.新型冠状病毒肺炎与新科学知识的产生：研究问题与研究设计。
J Eval Clin Pract. 2021 Jun;27(3):694-707. doi: 10.1111/jep.13550. Epub 2021 Feb 15.
4
COVID-19 and the generation of novel scientific knowledge: Evidence-based decisions and data sharing.新型冠状病毒肺炎与新型科学知识的产生：循证决策与数据共享。
J Eval Clin Pract. 2021 Jun;27(3):708-715. doi: 10.1111/jep.13548. Epub 2021 Feb 13.
5
A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.葡萄糖-6-磷酸脱氢酶缺乏症 COVID-19 患者接受羟氯喹后发生严重溶血的病例报告。
Infect Dis (Lond). 2020 Sep;52(9):659-661. doi: 10.1080/23744235.2020.1774644. Epub 2020 Jun 4.
本文引用的文献
1
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.埃博拉病毒病治疗的随机、对照试验。
N Engl J Med. 2019 Dec 12;381(24):2293-2303. doi: 10.1056/NEJMoa1910993. Epub 2019 Nov 27.
2
Research Ethics Governance in Times of Ebola.埃博拉疫情期间的研究伦理治理
Public Health Ethics. 2017 Apr;10(1):49-61. doi: 10.1093/phe/phw039. Epub 2016 Nov 1.
3
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).一种重组水疱性口炎病毒载体疫苗预防埃博拉病毒病的有效性和效果：几内亚环状疫苗接种、开放标签、整群随机试验（埃博拉到此为止！）的最终结果
Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23.
Zotero 插件